Stock Alert: Centogene Rises 11% On Receiving EUA For Vovid-19 Test

(RTTNews) - Shares of Centogene N.V. (CNTG) are rising more than 11% Monday morning after the company said it has received Emergency Use Authorization (EUA) from the FDA for 'CentoSure', the company's latest SARS-CoV-2 RT-PCR test.

The EUA allows to use this test to use for individuals with no symptoms of Covid-19 or other reasons to suspect the disease.

Centogene stock is currently trading at $12.11. It has been trading in the range of $7.80- $28.71 in the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More